Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06390111
Status:
RECRUITING
Last Update Posted:
2024-06-28
First Post:
2024-04-19
Brief Title:
A Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS High-grade TaT1 and no Complete Response to First Nadofaragene Firadenovec Dose
Sponsor:
Ferring Pharmaceuticals
Organization:
Ferring Pharmaceuticals
Organization Data
Organization:
Ferring Pharmaceuticals
Class:
INDUSTRY
Study ID:
000439
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ferring Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None